WHO Raises Warning Over Severe Lack of Obesity Medications
Fewer than 10% of individuals that would benefit from obesity jabs like Wegovy can access them, caution the World Health Organization as it releases its first advice on the therapies.
With in excess of 1,000,000,000 people worldwide now living with obesity, it is advocating for more widespread and fairer access to these injectable treatments.
Per estimates, in excess of 2,000,000,000 are projected to be obese by 2030 without intervention.
"The latest guidelines recognises that excess weight is a long-term condition that can be treated with comprehensive and lifelong support," remarked the agency's head Tedros Adhanom Ghebreyesus.
High costs, constrained manufacturing, and logistical bottlenecks are major obstacles to universal availability to the injections that can help people shift significant body mass, says the body.
Weight-Loss Drug Supply Crisis
Despite the current best projected outlook, the production of GLP-1 therapies would only suffice for about 100 million people – fewer than 10% of the global need, per the health organization.
The advice calls on countries and companies to widen availability, via measures including voluntary licensing.
The intellectual property rights on a key compound – the core ingredient of a leading brand – is due to expire in multiple countries in 2026.
The Way Obesity Drugs Operate
The injections mimick a natural hormone to reduce digestion speed, reduce hunger and enhance satiety so individuals consume fewer calories.
People commonly begin shedding pounds after several weeks of starting on the regular doses.
Studies suggests users may regain a significant portion a year later of stopping the treatment, when their usual food cravings come back.
Being carrying excess weight raises your risk for developing medical conditions, including type 2 diabetes, cardiovascular issues, stroke, and some malignancies.
Excess weight impacts individuals in every country and was linked to 3.7 million deaths worldwide in 2024, according to the WHO.
